These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 19077081

  • 1. Reactivation of hepatitis B two years after rituximab therapy in a renal transplant patient with recurrent focal segmental glomerulosclerosis: a note of caution.
    Gossmann J, Scheuermann EH, Kachel HG, Geiger H, Hauser IA.
    Clin Transplant; 2009; 23(3):431-4. PubMed ID: 19077081
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
    Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, Chan HL, Hui EP, Lei KI, Mok TS, Chan PK.
    J Clin Oncol; 2009 Feb 01; 27(4):605-11. PubMed ID: 19075267
    [Abstract] [Full Text] [Related]

  • 3. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M, Ampuero J, Anaya F.
    Transplant Proc; 2009 Feb 01; 41(6):2406-8. PubMed ID: 19715934
    [Abstract] [Full Text] [Related]

  • 4. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis.
    Meyer TN, Thaiss F, Stahl RA.
    Transpl Int; 2007 Dec 01; 20(12):1066-71. PubMed ID: 17887957
    [Abstract] [Full Text] [Related]

  • 5. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
    Gossmann J, Scheuermann EH, Porubsky S, Kachel HG, Geiger H, Hauser IA.
    Transpl Int; 2007 Jun 01; 20(6):558-62. PubMed ID: 17433091
    [Abstract] [Full Text] [Related]

  • 6. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.
    Dello Strologo L, Guzzo I, Laurenzi C, Vivarelli M, Parodi A, Barbano G, Camilla R, Scozzola F, Amore A, Ginevri F, Murer L.
    Transplantation; 2009 Aug 15; 88(3):417-20. PubMed ID: 19667947
    [Abstract] [Full Text] [Related]

  • 7. Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation.
    Tsagalis G, Psimenou E, Nakopoulou L, Laggouranis A.
    Artif Organs; 2011 Apr 15; 35(4):420-5. PubMed ID: 20637013
    [Abstract] [Full Text] [Related]

  • 8. High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients.
    Matsue K, Aoki T, Odawara J, Fujiwara H, Iwama K, Kimura S, Yamakura M, Takeuch M.
    Eur J Haematol; 2009 Oct 15; 83(4):357-64. PubMed ID: 19508685
    [Abstract] [Full Text] [Related]

  • 9. The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma.
    He YF, Li YH, Wang FH, Jiang WQ, Xu RH, Sun XF, Xia ZJ, Huang HQ, Lin TY, Zhang L, Bao SP, He YJ, Guan ZZ.
    Ann Hematol; 2008 Jun 15; 87(6):481-5. PubMed ID: 18299831
    [Abstract] [Full Text] [Related]

  • 10. Rituximab for post-transplant recurrences of FSGS.
    Bayrakci US, Baskin E, Sakalli H, Karakayali H, Haberal M.
    Pediatr Transplant; 2009 Mar 15; 13(2):240-3. PubMed ID: 18822107
    [Abstract] [Full Text] [Related]

  • 11. Protocol biopsies for focal segmental glomerulosclerosis treated with plasma exchange and rituximab in a renal transplant patient.
    Sakai K, Takasu J, Nihei H, Yonekura T, Aoki Y, Kawamura T, Mizuiri S, Aikawa A.
    Clin Transplant; 2010 Jul 15; 24 Suppl 22():60-5. PubMed ID: 20590697
    [Abstract] [Full Text] [Related]

  • 12. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.
    Bremer CT, Lastrapes A, Alper AB, Mudad R.
    Am J Clin Oncol; 2003 Jun 15; 26(3):262-4. PubMed ID: 12796597
    [Abstract] [Full Text] [Related]

  • 13. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
    Wu JM, Huang YH, Lee PC, Lin HC, Lee SD.
    J Clin Gastroenterol; 2009 Jun 15; 43(5):496-8. PubMed ID: 19247200
    [Abstract] [Full Text] [Related]

  • 14. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
    Huang H, Cai Q, Lin T, Lin X, Liu Y, Gao Y, Peng R.
    Expert Opin Pharmacother; 2009 Oct 15; 10(15):2399-406. PubMed ID: 19761353
    [Abstract] [Full Text] [Related]

  • 15. Focal segmental glomerulosclerosis as a complication of hepatitis B virus infection.
    Sakai K, Morito N, Usui J, Hagiwara M, Hiwatashi A, Fukuda K, Nanmoku T, Toda T, Matsui N, Nagata M, Yamagata K.
    Nephrol Dial Transplant; 2011 Jan 15; 26(1):371-3. PubMed ID: 20959346
    [Abstract] [Full Text] [Related]

  • 16. Reactivation of hepatitis B virus with rituximab.
    Tsutsumi Y, Kanamori H, Mori A, Tanaka J, Asaka M, Imamura M, Masauzi N.
    Expert Opin Drug Saf; 2005 May 15; 4(3):599-608. PubMed ID: 15934864
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab.
    Hristea D, Hadaya K, Marangon N, Buhler L, Villard J, Morel P, Martin PY.
    Transpl Int; 2007 Jan 15; 20(1):102-5. PubMed ID: 17181660
    [Abstract] [Full Text] [Related]

  • 18. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
    Peters HP, van de Kar NC, Wetzels JF.
    Neth J Med; 2008 Nov 15; 66(10):408-15. PubMed ID: 19011266
    [Abstract] [Full Text] [Related]

  • 19. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.
    J Pediatr Gastroenterol Nutr; 2009 Feb 15; 48(2):203-8. PubMed ID: 19179883
    [Abstract] [Full Text] [Related]

  • 20. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment.
    Pescovitz MD, Book BK, Sidner RA.
    N Engl J Med; 2006 May 04; 354(18):1961-3. PubMed ID: 16672715
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.